US Broker Ratings

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: Navigating the Biotech Sector with a 23.7% Revenue Growth

Amicus Therapeutics, Inc. (NASDAQ: FOLD) has been making waves in the biotechnology industry, a sector known for its potential to deliver transformative healthcare solutions and significant..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 56.76% Potential Upside in Biotech

Vericel Corporation (NASDAQ: VCEL), a dynamic player in the biotechnology sector, offers a captivating prospect for investors with its focus on innovative cellular therapies and specialty..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Navigating a Challenging Landscape with Insights into Valuation and Dividend Potential

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a key player in the medical instruments and supplies industry, commands attention with its robust market presence in the healthcare sector...

Certara, Inc. (CERT) Stock Analysis: Exploring a 38% Potential Upside in Health Information Services

Certara, Inc. (NASDAQ: CERT), a notable player in the healthcare sector, offers a compelling narrative with its technology-driven services and software products designed for biosimulation. As..

Apogee Therapeutics (APGE) Stock Analysis: Exploring a 47.76% Potential Upside in the Biotech Sector

Apogee Therapeutics, Inc. (NASDAQ: APGE) is a promising name in the biotechnology industry, boasting a market capitalization of $4.84 billion. Operating within the healthcare sector, Apogee..

LivaNova PLC (LIVN) Stock Analysis: A Promising Upside of 13.72% Amid Robust Revenue Growth

LivaNova PLC (NASDAQ: LIVN), a key player in the healthcare sector’s medical devices industry, is capturing investor attention with its robust revenue growth and significant potential..

BioCryst Pharmaceuticals, Inc. (BCRX) Stock Analysis: Exploring a 146.81% Potential Upside in the Biotech Sector

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is making waves in the biotech sector, marked by a robust market capitalization of $2.16 billion and a promising pipeline of..

Apellis Pharmaceuticals (APLS) Stock Analysis: Exploring a 62.73% Upside Potential in Biotech

For investors with a keen interest in the biotechnology sector, Apellis Pharmaceuticals, Inc. (NASDAQ: APLS) presents an intriguing opportunity. The company, headquartered in Waltham, Massachusetts, focuses..

Ligand Pharmaceuticals (LGND): Investor Outlook with 20.74% Potential Upside

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), a prominent player in the biotechnology sector, is making waves in the healthcare industry with a market capitalization of $3.99 billion...

Alignment Healthcare, Inc. (ALHC) Stock Analysis: 29.77% Potential Upside Sparks Investor Interest

Alignment Healthcare, Inc. (NASDAQ: ALHC) is drawing considerable attention from investors, courtesy of its robust growth metrics and optimistic analyst ratings. As a significant player in..

Catalyst Pharmaceuticals (CPRX) Stock Analysis: Uncovering a 41% Potential Upside in the Biotech Sector

Catalyst Pharmaceuticals, Inc. (CPRX) is drawing attention in the healthcare sector, particularly within the biotechnology industry, due to its promising potential for growth and profitability. With..

Xenon Pharmaceuticals (XENE) Investor Outlook: Potential 32.79% Upside Amid Robust Analyst Confidence

Xenon Pharmaceuticals Inc. (XENE), a leader in the biotechnology sector specializing in neuroscience-focused therapeutics, is capturing investor attention with its promising portfolio and potential upside of..

Belite Bio, Inc (BLTE) Stock Analysis: A Biotech Contender with Promising 14.88% Upside

Belite Bio, Inc (NASDAQ: BLTE) has become a notable player in the biotechnology sector, intriguing investors with its promising pipeline and a potential upside of 14.88%...

Sotera Health Company (SHC) Stock Analysis: Exploring a 30% Potential Upside in the Healthcare Sector

Sotera Health Company (NASDAQ: SHC) stands as a prominent player within the healthcare sector, specifically in the diagnostics and research industry. With a market capitalization of..

Immunovant, Inc. (IMVT) Stock Analysis: A Compelling 48.2% Upside Potential in the Biotech Sector

Immunovant, Inc. (NASDAQ: IMVT) continues to capture the attention of investors, particularly those with an eye for emerging opportunities in the healthcare sector. As a clinical-stage..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Opportunities in Healthcare with 15% Revenue Growth

Envista Holdings Corporation (NYSE: NVST) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Brea, California, Envista..

Perrigo Company plc (PRGO) Stock Analysis: High Dividend Yield Offers Tempting 37.76% Potential Upside

Perrigo Company plc (NYSE: PRGO) stands out in the healthcare sector, specifically within the drug manufacturers – specialty and generic industry, with a market capitalization of..

PTC Therapeutics, Inc. (PTCT)

⚠️ No article content returned.

..

Inspire Medical Systems, Inc. (INSP): Evaluating Growth Potential in the Medical Device Sector

Inspire Medical Systems, Inc. (NASDAQ: INSP), a prominent player in the healthcare sector specializing in medical devices, is making waves with its innovative solutions for obstructive..

Regencell Bioscience Holdings L (RGC): Unpacking the High Volatility and Unique Market Position in TCM

Regencell Bioscience Holdings Limited (NASDAQ: RGC) presents a unique investment opportunity with its distinct focus on Traditional Chinese Medicine (TCM) for neurocognitive disorders. Based in Hong..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds